News | April 03, 2008

St. Jude's CRT-D, ICD Extend their Lead with Durata

April 4, 2008 - St. Jude Medical placed at center stage at ACC the company’s Promote RF CRT-D and Current ICD, combined with the new Durata lead, and the QuickOpt Timing Cycle Optimization.

The Promote RF CRT-D and Current RF ICD, which feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.

The Durata defibrillation lead is the first St. Jude Medical lead with an innovative soft lead tip and slightly curved RV coil, designed to optimize the lead tip-endocardium interface.

Representing the latest advancements in lead technology, the Durata lead features exclusive technologies designed for long-term reliability, more control during implantation, and options to accommodate varying patient needs and physician preferences - all while being the thinnest of any competitive lead on the market.

QuickOpt Timing Cycle Optimization was another tool on display, offering alternative to time-consuming echocardiography procedures. By programming appropriate AV and VV delays (timing cycle optimization), research has shown to be effective at improving patient outcomes by increasing cardiac output and reducing non-responder rates.

Related Content

Medtronic Begins Pilot Study of Investigational Extravascular ICD System
News | Implantable Cardioverter Defibrillator (ICD) | August 09, 2018
Medtronic plc announced the start of a pilot study of its investigational Extravascular Implantable Cardioverter...
ICD Placements Not Meeting Medicare Coverage Criteria Decline After Overuse Investigation Announced
Feature | Implantable Cardioverter Defibrillator (ICD) | July 11, 2018
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS...
New Tool Predicts Benefits and Risks of Implantable Defibrillator for Heart Failure Patients
News | Implantable Cardioverter Defibrillator (ICD) | July 02, 2018
University of Washington (UW) Medicine cardiologists have developed a tool to predict which heart-failure patients...
Real-World Data Demonstrates Success Of Smart Pass Filter on Boston Scientific S-ICD System
News | Implantable Cardioverter Defibrillator (ICD) | May 16, 2018
Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of...
Online Message Board Advice on ICDs Reflects Inaccuracies
News | Implantable Cardioverter Defibrillator (ICD) | April 13, 2018
April 13, 2018 — Medical advice about implanted cardiac defibrillators obtained via an online message board appears t
Biotronik U.S. to Distribute Aziyo ECM Envelopes
News | Implantable Cardioverter Defibrillator (ICD) | April 12, 2018
Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's CanGaroo...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD) | September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD) | September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD) | July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD) | June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Overlay Init